Pumaprazole
CAS No. 158364-59-1
Pumaprazole ( BY-841 )
产品货号. M26799 CAS No. 158364-59-1
普马拉唑是可逆质子泵的拮抗剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1881 | 有现货 |
|
| 10MG | ¥3126 | 有现货 |
|
| 25MG | ¥4910 | 有现货 |
|
| 50MG | ¥6752 | 有现货 |
|
| 100MG | ¥8811 | 有现货 |
|
| 200MG | ¥11880 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥2166 | 有现货 |
|
生物学信息
-
产品名称Pumaprazole
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述普马拉唑是可逆质子泵的拮抗剂。
-
产品描述Pumaprazole is an antagonist of a reversible proton pump.(In Vivo):Pumaprazole shows identical ID50 values on day 1 (11 μmol/kg, 95% confidence limits of 5 and 23), and on day 7 (10 μmol/kg, 95% confidence limits of 4 and 23) of a repeated dose study in this model. Basal acid secretion in the Ghosh-Schild rat is inhibited by Pumaprazole with a higher efficacy compared to ranitidine. The lower dose of Pumaprazole (27 μmol/kg) rapidly elevates luminal pH up to almost neutrality, the higher dose (54 μmol/kg) further prolongs this pH-elevating effect.
-
体外实验——
-
体内实验Pumaprazole is a reversible proton pump antagonist. Basal acid secretion in the Ghosh-Schild rat is inhibited by Pumaprazole with a higher efficacy compare to ranitidine. Pumaprazole displays identical ID50 values on day 1 (11 μmol/kg, 95% confidence limits of 5 and 23) and on day 7 (10 μmol/kg, 95% confidence limits of 4 and 23) of a repeated dose study in this model. The lower dose of Pumaprazole (27 μmol/kg) rapidly elevates luminal pH up to almost neutrality, the higher dose (54 μmol/kg) further prolongs this pH-elevating effect.
-
同义词BY-841
-
通路Membrane Transporter/Ion Channel
-
靶点Proton Pump
-
受体TXNIP-TRX complex
-
研究领域——
-
适应症——
化学信息
-
CAS Number158364-59-1
-
分子量338.411
-
分子式C19H22N4O2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (295.51 mM)
-
SMILESCOC(=O)Nc1cccc(C)c1CNc1cccn2c(C)c(C)nc12
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Rama Natarajan, et al. Txnip-trx complex inhibitors and methods of using the same. US20200085800A1.
产品手册
关联产品
-
Tegoprazan
一种新型强效、高选择性、竞争性和口服活性的胃 H+/K+-ATP 酶抑制剂,体外猪、犬和人 H+/K+-ATP 酶的 IC50 范围为 0.29-0.52 uM。
-
Esomeprazole
埃索美拉唑是奥美拉唑的S异构体,通过抑制溶酶体半胱氨酸蛋白酶legumain来预防癌症转移。
-
Revaprazan hydrochlo...
Revaprazan (SB-641257;YH-1885) 有效的钾竞争性酸阻滞剂 (P-CAB),以可逆和 K+ 竞争性方式抑制 H+,K+-ATP 酶。
021-51111890
购物车()
sales@molnova.cn

